Ronald Lizée
Director Financiero/CFO en Acrongenomics, Inc. .
Perfil
Ronald Lizée is currently the President & Chief Executive Officer at Gemstar Capital Properties, Inc. He is also the Chief Financial Officer at Acrongenomics, Inc. Previously, he served as the Chief Financial Officer, Treasurer & Director at PreAxia Health Care Payment Systems, Inc. from 2008 to 2011.
Additionally, he was the Chief Financial Officer at Sun World Partners, Inc. from 2008 to 2009.
Mr. Lizée obtained his undergraduate degree from the University of Saskatchewan in 1981.
Cargos activos de Ronald Lizée
| Empresas | Cargo | Inicio |
|---|---|---|
Acrongenomics, Inc.
 Acrongenomics, Inc. Medical SpecialtiesHealth Technology Acrongenomics, Inc. engages in the development and commercialization ofnovel biotechnology platforms in the Life Science sector as well as introducing and developing new compounds in the Pharmaceutical sector. The company was founded on August 17, 1999 and is headquartered in London, the United Kingdom. | Director Financiero/CFO | 04/06/2004 |
| Gemstar Capital Properties, Inc. | Director Ejecutivo | 02/03/2010 |
Antiguos cargos conocidos de Ronald Lizée.
| Empresas | Cargo | Fin |
|---|---|---|
| PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. | Director Financiero/CFO | 24/11/2011 |
| Sun World Partners, Inc. | Director Financiero/CFO | 15/01/2009 |
Formación de Ronald Lizée.
| University of Saskatchewan | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PREAXIA HEALTH CARE PAYMENT SYSTEMS INC. | Technology Services |
| Empresas privadas | 3 |
|---|---|
Acrongenomics, Inc.
Acrongenomics, Inc. Medical SpecialtiesHealth Technology Acrongenomics, Inc. engages in the development and commercialization ofnovel biotechnology platforms in the Life Science sector as well as introducing and developing new compounds in the Pharmaceutical sector. The company was founded on August 17, 1999 and is headquartered in London, the United Kingdom. | Health Technology |
| Sun World Partners, Inc. | Retail Trade |
| Gemstar Capital Properties, Inc. |
- Bolsa de valores
- Insiders
- Ronald Lizée
